Vagus Nerve Stimulation trials

Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye

RecruitingNCT06696625Phase: NAStarted 2021-07-01

Summary

Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease. Methods: The investigators enrolled 256 patients at Beijing Tongre

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Locations

China Beijing TongRen Hospital, Capital Medical University BBeijing, Beijing Municipality, China

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06696625